Therefore, medications that can reduce the activity of acetylcholinesterase, such as Donepezil and Rivastigmine, can be used to increase the level of ACh in the synaptic cleft and improve cognitive function in AD patients [56–60]. This evidence concerns the gene ACHE and Alzheimer disease.